Qatar Tribune on MSN
Sidra Medicine successfully completes first pediatric allogeneic hematopoietic stem cell transplantation (HSCT)
Sidra Medicine completes Qatar’s first pediatric allogeneic HSCT, advancing life-saving stem cell care for children with ...
The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...
The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and ...
MedPage Today on MSN
First Drug for Deadly Transplant Complication Gets FDA's Blessing
The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...
Doha: Sidra Medicine has announced the successful completion of its first pediatric allogeneic hematopoietic stem cell transplantation (HSCT), ...
A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their cornea. The clinical trial, which took place in Japan, is the first of its kind ...
MedPage Today on MSN
Potential Game-Changing Impact on Mismatched Unrelated Blood Cell Transplantation
Patients with <7/8 transplants had a 1-year survival of 85.6% versus 78.6% for those who received better-matched donor cells.
Rare case shows a man living virus free for years after stopping treatment, raising new questions about how the immune system ...
The Hearty Soul on MSN
Man unexpectedly cured from HIV after stem cell transplant
A few decades ago, the idea of an HIV cure sounded unrealistic. Today, doctors describe a carefully documented case where the ...
Cancer patients who are denied a second stem cell transplant by the NHS are being handed a “death sentence”, a Conservative ...
During events to find a blood stem cell donor for Eddie Kaufman, volunteers had their cheeks swabbed. One of those volunteers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback